Peptide News Digest

#Behavioral-Health

1 story

Research · View digest

Omada Health: 12-Week GLP-1 Care Track Delivers 2.1x More Fat Loss While Preserving Muscle Mass

Omada Health published results from a 12-week study of 245 adults with obesity comparing its GLP-1 Care Track behavioral program (151 members) to a control group (94). Omada members lost 1.8x more total weight (6.0% vs 3.3% of starting weight), 2.1x more body fat, and saw increased muscle mass percentage and improved mental health scores. The finding directly addresses sarcopenia concerns highlighted in recent NPR coverage of GLP-1 discontinuation.